The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Trial

Recruiting N/A Interventional Study
Small Bowel Obstruction Intestinal Obstruction and Ileus
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,000 (estimated)
Sponsor
University Hospital, Linkoeping · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Small bowel obstruction (SBO) is a surgical emergency where the normal continuous bowel movements are hindered and approximately 8000-9000 patients visit the emergency department every year in Sweden due to SBO. A minority of these have evidence of intestinal injury, warranting emergency surgery, while the majority (70-90%) will have an initial plan for non-operative management with a …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Small bowel obstruction diagnosed on Computer Tomography Exclusion Criteria: * Nasogastric Tube already places * Amyotrophic lateral sclerosis * Cerebral palsy * Dementia * Parkinson's disease * Multiple Sclerosis * Previous stroke with documented persistent dysphagia * Plan…
Contacts

Jens Wretborn, Associate Professor

+46101030000

jens.wretborn@liu.se

CONTACT

Erika Johannesson, MSc

+46101030000

CONTACT